PA
GH icon

Parallel Advisors’s Guardant Health GH Stock Holding History

Parallel Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118K Buy
783
+424
+118% +$46.1K ﹤0.01% 1595
2026
Q1 		$33.2K Buy
359
+7
+2% +$703 ﹤0.01% 2224
2025
Q4 		$36K Buy
352
+219
+165% +$19.6K ﹤0.01% 2023
2025
Q3 		$8.34K Buy
133
+15
+13% +$816 ﹤0.01% 2592
2025
Q2 		$6.12K Sell
118
-23
-16% -$1.03K ﹤0.01% 2664
2025
Q1 		$6.01K Buy
141
+63
+81% +$2.72K ﹤0.01% 2617
2024
Q4 		$2.38K Buy
78
+18
+30% +$506 ﹤0.01% 2911
2024
Q3 		$1.38K Sell
60
-36
-38% -$1.02K ﹤0.01% 2971
2024
Q2 		$2.77K Buy
+96
New +$2.23K ﹤0.01% 2704
2024
Q1 		– Sell
-1,219
Closed -$33K – 3354
2023
Q4 		$33K Sell
1,219
-102
-8% -$2.68K ﹤0.01% 1652
2023
Q3 		$39.2K Buy
1,321
+76
+6% +$2.67K ﹤0.01% 1511
2023
Q2 		$44.6K Buy
1,245
+137
+12% +$3.93K ﹤0.01% 1457
2023
Q1 		$26K Sell
1,108
-26
-2% -$743 ﹤0.01% 1703
2022
Q4 		$30.8K Buy
1,134
+68
+6% +$3.11K ﹤0.01% 1512
2022
Q3 		$57K Buy
1,066
+676
+173% +$34.7K ﹤0.01% 1204
2022
Q2 		$16K Sell
390
-4
-1% -$198 ﹤0.01% 1762
2022
Q1 		$26K Buy
394
+17
+5% +$1.16K ﹤0.01% 1593
2021
Q4 		$38K Buy
377
+259
+219% +$26.8K ﹤0.01% 1470
2021
Q3 		$15K Sell
118
-54
-31% -$6.42K ﹤0.01% 1875
2021
Q2 		$21K Sell
172
-1,188
-87% -$160K ﹤0.01% 1653
2021
Q1 		$208K Sell
1,360
-165
-11% -$24.9K 0.01% 631
2020
Q4 		$197K Sell
1,525
-101
-6% -$11.6K 0.01% 590
2020
Q3 		$182K Buy
1,626
+170
+12% +$15.6K 0.01% 594
2020
Q2 		$118K Sell
1,456
-2,930
-67% -$236K 0.01% 705
2020
Q1 		$305K Buy
4,386
+4,355
+14,048% +$334K 0.02% 347
2019
Q4 		$2K Hold
31
– – ﹤0.01% 2201
2019
Q3 		$2K Hold
31
– – ﹤0.01% 2168
2019
Q2 		$3K Buy
31
+11
+55% +$840 ﹤0.01% 1983
2019
Q1 		$2K Buy
+20
New +$1.11K ﹤0.01% 2076

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Parallel Advisors's GH Position: Q2 2026 in Review

Parallel Advisors increased its Guardant Health (GH) stake by 118% in Q2 2026, buying an estimated $46.1K and bringing the position to 783 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #1595.

Parallel Advisors first reported a position in GH in Q1 2019 and has held it in 29 quarters since. The position peaked at $305K in Q1 2020. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Parallel Advisors held 783 shares of Guardant Health worth $118K as of Q2 2026.
  • Parallel Advisors bought 424 Guardant Health shares in Q2 2026, an estimated $46.1K.
  • Guardant Health made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #1595 holding.
  • Parallel Advisors first reported a position in Guardant Health in Q1 2019 and has held it in 29 quarters since.
  • Parallel Advisors's Guardant Health position peaked at $305K in Q1 2020.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.